Schenlein-Genoch's Disease In Children: Clinical Characteristics

Authors

  • Guloyim S.Avezova Phd Dotsent, Tashkent Medical Academy
  • Nafisa S.Sultanova DSc, Dotsent, Tashkent Medical Academy
  • Jurabek Azimov Student, Tashkent Medical Academy

DOI:

https://doi.org/10.62480/tjms.2025.vol40.pp31-35

Keywords:

hemorrhagic vasculitis, Schönlein-Henoch disease, clinical, children

Abstract

The article retrospectively analyzes the clinical course of hemorrhagic vasculitis in children and the characteristics of the course in children with associated pathologies. Currently, hemorrhagic vasculitis is one of the most common and frequent pathologies in the pediatric population. Its frequency is very variable and depends on the region, its level of economic development, diagnostic and statistical features. Various manifestations of hemorrhagic vasculitis clinical signs, the severity of the course of the disease, the consequences largely depend on the state of the coagulation and anticoagulation systems of hemostasis, and which organ is damaged, and kidney damage determines the probability of a severe course of the disease.

References

Avezova G.S. Changes in the hemostasis system in children with hemorrhagic vasculitis // TTA

newsletter .-2023- №9, p. 223-229. (uzb)

Kudryasheva M.A. Pathogeneticheskie faktori techenia i ikhoda disease Shenleyna-Genoxa u detey//

diss.kand med nauk., Moscow -2015, 176 str. (Russian)

Khramtsova A. S., Yakovleva A. V. Kliniko-epidemiologicheskie osobennosti hemorragicheskogo

vasculita u detey //Molodej-prakticheskomu zdrooochraneniyu. - 2018. - S. 1018-1020(Russian)

Butbul Aviel Y, Dafna L, Pilar G, Brik R. Endothelial function in children with a history of henoch

schonlein purpura // Pediatr Rheumatol Online J. – 2017. - №15(1). – Р. 3-11.

Hahn D, Hodson E.M, Willis N.S, Craig J.C. Interventions for preventing and treating kidney

disease in Henoch-Schönlein Purpura (HSP) // Cochrane Database of Systematic Reviews. – 2015. -

Issue 8. – Р. 74-81.

Jiang MY, Li W, Xu XP, Zhou JQ, Jiang H. Role of p300 in the pathogenesis of Henoch-Schonlein

purpura nephritis and as a new target of glucocorticoid therapy in mice // Chin Med J (Engl). – 2019.

- №132(16). – Р. 1942–1950.

Mir S., Yavascan O., Mutlubas F. et al. Clinical outcome in children with Henoch-Schönlein

nephritis // Pediatr Nephrol. – 2007. – Vol. 22(1). – P.64-70.

Wang X, Zhu Y, Gao L, Wei S, Zhen Y, Ma Q. Henoch-Schönlein purpura with joint involvement:

Analysis of 71 cases // Pediatr Rheumatol Online J. – 2016. - №14(1). – Р. 20-26.

Brogan P., Eleftheriou D., Dillon M. Small vessel vasculitis // Pediatr Nephrol. – 2010. – Vol. 25(6).

– P.1025-35.

Gedalia A. Henoch-Schönlein purpura. Curr Rheumatol Rep // 2004. – Vol. 6(3). – P.195-202.

Bogdanović R. Henoch-Schönlein purpura nephritis in children: risk factors, prevention and

treatment // Acta Paediatr. – 2009. – Vol. 98(12). – P.1882-9.

Chang W.L., Yang Y.H., Wang L.C. et al. Renal manifestations in Henoch-Schönlein purpura: a 10-

year clinical study // Pediatr Nephrol. – 2005. – Vol. 20(9). – P.1269-72.

Chao H.C., Kong M.S., Lin S.J. et al. Gastrointestinal manifestation and outcome of HenochSchonlein purpura in children // Chang Gung Med J. – 2000. – Vol. 23(3). – P.135-41.

Chen S.Y., Kong M.S. Gastrointestinal manifestations and complications of Henoch-Schönlein

purpura // Chang Gung Med J. – 2004. – Vol. 27(3). – P.175-81.

Kawasaki Y., Ono A., Ohara S. et al. Henoch-Schönlein purpura nephritis in childhood:

pathogenesis, prognostic factors and treatment // Fukushima J Med Sci. – 2013. – Vol. 59(1). – P.15-

Downloads

Published

2025-01-28

Issue

Section

Articles

How to Cite

Schenlein-Genoch’s Disease In Children: Clinical Characteristics. (2025). Texas Journal of Medical Science, 40, 31-35. https://doi.org/10.62480/tjms.2025.vol40.pp31-35